Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial dysfunction and oxidative stress in Alzheimer’s disease, and Parkinson’s disease, Huntington’s disease and Amyotrophic Lateral Sclerosis -An updated review
Taha Alqahtani, S. L. Deore, Anjali A. Kide, et al.
Mitochondrion (2023) Vol. 71, pp. 83-92
Closed Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Mitochondria Dysfunction and Neuroinflammation in Neurodegeneration: Who Comes First?
Caterina Peggion, Tito Calì, Marisa Brini
Antioxidants (2024) Vol. 13, Iss. 2, pp. 240-240
Open Access | Times Cited: 25
Targeting Mitochondrial Dysfunction and Reactive Oxygen Species for Neurodegenerative Disease Treatment
Eui-Hwan Choi, Mi-Hye Kim, Sun-Ji Park
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7952-7952
Open Access | Times Cited: 22
Neuroinflammation and neurodegeneration in Huntington’s disease: genetic hallmarks, role of metals and organophosphates
Omkar Kumar Kunwar, Shamsher Singh
Neurogenetics (2025) Vol. 26, Iss. 1
Closed Access | Times Cited: 2
Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches
Gökhan Burçin Kubat, Pasquale Picone
Neurological Sciences (2024) Vol. 45, Iss. 9, pp. 4121-4131
Open Access | Times Cited: 10
Neuroprotective Benefits of Rosmarinus officinalis and Its Bioactives against Alzheimer’s and Parkinson’s Diseases
Danai Kosmopoulou, Maria-Parthena Lafara, Theodora Adamantidi, et al.
Applied Sciences (2024) Vol. 14, Iss. 15, pp. 6417-6417
Open Access | Times Cited: 10
Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington’s disease
Alaa Shafie, Amal Adnan Ashour, Saleha Anwar, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 6, pp. 571-595
Closed Access | Times Cited: 9
Neuroprotective Effects of Olive Oil: A Comprehensive Review of Antioxidant Properties
Marta Gonçalves, Nuno Vale, Paula Silva
Antioxidants (2024) Vol. 13, Iss. 7, pp. 762-762
Open Access | Times Cited: 9
From Brain to Muscle: The Role of Muscle Tissue in Neurodegenerative Disorders
Elisa Duranti, Chiara Villa
Biology (2024) Vol. 13, Iss. 9, pp. 719-719
Open Access | Times Cited: 8
Sleep deprivation accelerates Parkinson's disease via modulating gut microbiota associated microglial activation and oxidative stress
Wenzhong Zhu, Yuan Hu, Yongping Shi, et al.
Microbiological Research (2025) Vol. 293, pp. 128077-128077
Closed Access | Times Cited: 1
Therapeutic modulation of mitochondrial dynamics by agmatine in neurodegenerative disorders
Dhanshree Nibrad, Amit Shiwal, Manasi Tadas, et al.
Neuroscience (2025)
Closed Access | Times Cited: 1
Postbiotics as Molecules Targeting Cellular Events of Aging Brain—The Role in Pathogenesis, Prophylaxis and Treatment of Neurodegenerative Diseases
Pola Głowacka, Katarzyna Oszajca, Agnieszka Pudlarz, et al.
Nutrients (2024) Vol. 16, Iss. 14, pp. 2244-2244
Open Access | Times Cited: 7
Mitochondrial quality control in non-exudative age-related macular degeneration: From molecular mechanisms to structural and functional recovery
Hernán H. Diéguez, Horacio E. Romeo, Agustina Alaimo, et al.
Free Radical Biology and Medicine (2024) Vol. 219, pp. 17-30
Closed Access | Times Cited: 6
A crazy trio in Parkinson's disease: metabolism alteration, α-synuclein aggregation, and oxidative stress
Sheng Li, Yanbing Liu, Sen Lu, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 6
Exploring the Comprehensive Neuroprotective and Anticancer Potential of Afzelin
Mateusz Kciuk, Nitika Garg, Sanchit Dhankhar, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 701-701
Open Access | Times Cited: 6
Nrf2 pathways in neuroprotection: Alleviating mitochondrial dysfunction and cognitive impairment in aging
Asif Ahmad Bhat, Ehssan Moglad, Ahsas Goyal, et al.
Life Sciences (2024) Vol. 357, pp. 123056-123056
Closed Access | Times Cited: 6
Targeting Mitochondrial Dysfunction and Oxidative Stress to Prevent the Neurodegeneration of Retinal Ganglion Cells
Elisabetta Catalani, Kashi Brunetti, Simona Del Quondam, et al.
Antioxidants (2023) Vol. 12, Iss. 11, pp. 2011-2011
Open Access | Times Cited: 13
Mild cognitive impairment in Huntington’s disease: challenges and outlooks
K. A. Jellinger
Journal of Neural Transmission (2024) Vol. 131, Iss. 4, pp. 289-304
Closed Access | Times Cited: 5
Mitochondrial targeted antioxidants as potential therapy for huntington’s disease
Shubham Upadhayay, Puneet Kumar
Pharmacological Reports (2024) Vol. 76, Iss. 4, pp. 693-713
Closed Access | Times Cited: 5
Dual Color Carbon Dots for Simultaneous Dynamic Fluorescence Tracking of Mitochondria and Lysosomes
Xinlu Li, Tongtong Zhu, Xiangli Quan, et al.
Sensors and Actuators B Chemical (2024), pp. 136678-136678
Closed Access | Times Cited: 5
ZLN005 alleviates PBDE-47 induced impairment of mitochondrial translation and neurotoxicity through PGC-1α/ERRα axis
Zhiyuan Tian, Jing Li, Huayang Tang, et al.
Journal of Hazardous Materials (2024) Vol. 471, pp. 134331-134331
Closed Access | Times Cited: 4
Innovative Therapeutic Strategies in Alzheimer’s Disease: A Synergistic Approach to Neurodegenerative Disorders
Sarfaraz K. Niazi, Matthias Magoola, Zamara Mariam
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 741-741
Open Access | Times Cited: 4
Harnessing the Therapeutic Potential of Peptides for Synergistic Treatment of Alzheimer’s Disease by Targeting Aβ Aggregation, Metal-Mediated Aβ Aggregation, Cholinesterase, Tau Degradation, and Oxidative Stress
Kamaljot Singh, Anupamjeet Kaur, Bhupesh Goyal, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 14, pp. 2545-2564
Closed Access | Times Cited: 4
Flavonoids and the gut microbiome: a powerful duo for brain health
Soroush Taherkhani, Parisa Ahmadi, Leila Roozbeh Nasiraie, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-16
Closed Access | Times Cited: 4
<italic>Gynostemma pentaphyllum</italic> extract ameliorates motor dysfunc-tion in mouse Parkinson<bold>’</bold>s disease model through inhibiting neuronal apoptosis
Tingting Zhao, Lei He, Sen Yan, et al.
Journal of Zhejiang University (Medical Sciences) (2025)
Closed Access
Decoding the influence of mitochondrial Ca2+ regulation on neurodegenerative disease progression
Jing Sun, Ge Gao, Sitong Wang, et al.
Mitochondrial Communications (2025) Vol. 3, pp. 1-15
Open Access
Page 1 - Next Page

Scroll to top